Mutations in IDH genes result in alteration of cellular metabolism, impaired cell adaptation mechanisms, epigenetic dysregulation, and they are associated with a poor prognosis in patients with AML [62,63,64,65]. Here, IDH1 is linked to acute myeloid leukemia.